News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
55,265 Results
Type
Article (5092)
Company Profile (1)
Press Release (50172)
Section
Business (8989)
Career Advice (5)
Deals (1402)
Drug Delivery (9)
Drug Development (27378)
Employer Resources (2)
FDA (2593)
Job Trends (1961)
News (38523)
Policy (3762)
Tag
Academia (98)
Accelerated approval (6)
Adcomms (17)
Allergies (25)
Alliances (1729)
ALS (30)
Alzheimer's disease (381)
Antibody-drug conjugate (ADC) (23)
Approvals (2601)
Artificial intelligence (12)
Autoimmune disease (3)
Automation (1)
Bankruptcy (16)
Best Places to Work (1990)
Biosimilars (19)
Biotechnology (1)
Bladder cancer (33)
Brain cancer (6)
Breast cancer (68)
Cancer (537)
Cardiovascular disease (73)
Career advice (6)
CAR-T (20)
Cell therapy (54)
Cervical cancer (9)
Clinical research (25634)
Collaboration (53)
Compensation (6)
Complete response letters (5)
COVID-19 (452)
CRISPR (4)
Cystic fibrosis (16)
Data (694)
Depression (19)
Diabetes (74)
Diagnostics (168)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (10)
Duchenne muscular dystrophy (46)
Earnings (6330)
Editorial (8)
Employer resources (2)
Events (5310)
Executive appointments (21)
FDA (2885)
Frontotemporal dementia (2)
Funding (37)
Gene editing (8)
Generative AI (1)
Gene therapy (61)
GLP-1 (186)
Government (466)
Grass and pollen (1)
Guidances (4)
Healthcare (926)
Huntington's disease (14)
IgA nephropathy (12)
Immunology and inflammation (20)
Indications (9)
Infectious disease (476)
Inflammatory bowel disease (33)
Influenza (6)
Intellectual property (2)
IPO (900)
IRA (4)
Job creations (132)
Job search strategy (4)
Kidney cancer (7)
Layoffs (92)
Leadership (1)
Legal (165)
Liver cancer (28)
Lung cancer (136)
Lymphoma (38)
Manufacturing (6)
MASH (38)
Medical device (684)
Medtech (684)
Mergers & acquisitions (521)
Metabolic disorders (180)
Multiple sclerosis (31)
NASH (16)
Neurodegenerative disease (33)
Neuropsychiatric disorders (15)
Neuroscience (572)
NextGen: Class of 2025 (241)
Non-profit (83)
Northern California (420)
Obesity (75)
Opinion (28)
Ovarian cancer (19)
Pain (21)
Pancreatic cancer (16)
Parkinson's disease (53)
Patents (14)
Patient recruitment (37)
Peanut (17)
People (982)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase I (3517)
Phase II (11151)
Phase III (12787)
Pipeline (273)
Policy (13)
Postmarket research (735)
Preclinical (437)
Press Release (7)
Prostate cancer (27)
Psychedelics (8)
Radiopharmaceuticals (15)
Rare diseases (93)
Real estate (84)
Recruiting (1)
Regulatory (3665)
Reports (3)
Research institute (102)
Rett syndrome (1)
RSV (13)
Schizophrenia (42)
Series A (8)
Series B (2)
Sickle cell disease (8)
Southern California (323)
Special edition (1)
Spinal muscular atrophy (61)
Sponsored (1)
Startups (89)
Stomach cancer (4)
Supply chain (2)
Tariffs (3)
The Weekly (4)
United States (3106)
Vaccines (102)
Venture capitalists (1)
Weight loss (41)
Women's health (6)
Date
Today (26)
Last 7 days (119)
Last 30 days (395)
Last 365 days (4892)
2025 (1464)
2024 (5012)
2023 (5204)
2022 (5438)
2021 (5804)
2020 (4853)
2019 (3662)
2018 (2746)
2017 (3500)
2016 (2578)
2015 (3045)
2014 (1888)
2013 (1192)
2012 (1265)
2011 (1291)
2010 (1201)
Location
Africa (27)
Alabama (21)
Arizona (6)
Asia (4213)
Australia (716)
California (908)
Canada (188)
China (96)
Colorado (24)
Connecticut (33)
Delaware (43)
Europe (9440)
Florida (93)
Georgia (32)
Illinois (48)
India (3)
Indiana (69)
Japan (46)
Kansas (12)
Kentucky (4)
Maine (2)
Maryland (84)
Massachusetts (562)
Michigan (9)
Minnesota (15)
Missouri (7)
Montana (1)
Nebraska (1)
Nevada (9)
New Hampshire (2)
New Jersey (422)
New York (290)
North Carolina (107)
Northern California (420)
Ohio (11)
Pennsylvania (164)
Rhode Island (1)
South America (38)
South Carolina (1)
Southern California (323)
Tennessee (3)
Texas (79)
Utah (20)
Virginia (15)
Washington D.C. (4)
Washington State (80)
Wisconsin (2)
55,265 Results for "endpoint clincal".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint
Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due to any cause or persistence of cancer cells by 32% in patients with high-risk non-muscle invasive bladder cancer.
April 28, 2025
·
1 min read
·
Tristan Manalac
Press Releases
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma
April 7, 2025
·
7 min read
Press Releases
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints
April 25, 2025
·
8 min read
Press Releases
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
April 28, 2025
·
6 min read
Press Releases
BREAKING: Dermata’s XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints
March 28, 2025
·
8 min read
Press Releases
Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD
March 31, 2025
·
1 min read
Press Releases
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
April 2, 2025
·
9 min read
Press Releases
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
March 31, 2025
·
6 min read
Press Releases
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
April 25, 2025
·
8 min read
Press Releases
Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint
March 26, 2025
·
10 min read
1 of 5,527
Next
